Superior vena cava syndrome with central venous catheter for chemotherapy treated successfully with fibrinolysis

Autor:	F. Sainz Gonzalez, R. F. Antón, A. Colmenarejo Rubio, L. Sáenz Cascos, R. Alguacil Rodríguez, J. F. Guijarro Escribano
Rok vydání:	2007
Předmět:	Cancer Research medicine.medical_specialty Catheterization Central Venous Superior Vena Cava Syndrome medicine.medical_treatment Antineoplastic Agents Breast Neoplasms Mastectomy Segmental Subclavian Vein Methylprednisolone Fibrinolytic Agents Superior vena cava Coumarins Fibrinolysis medicine Humans Thrombolytic Therapy cardiovascular diseases Endovascular treatment Infusions Intravenous Urokinase Chemotherapy Superior vena cava syndrome business.industry Anticoagulants General Medicine Middle Aged Combined Modality Therapy Urokinase-Type Plasminogen Activator Surgery Catheter Oncology Chemotherapy Adjuvant cardiovascular system Drug Therapy Combination Female Radiotherapy Adjuvant medicine.symptom business Central venous catheter medicine.drug
Zdroj:	Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 9(3)
ISSN:	1699-048X
Popis:	Recently, there has been an increase in the number of cases of superior vena cava (SVC) syndrome associated with chronic indwelling central venous catheters. Fibrinolytic therapy and endovascular treatment are currently achieving good results. We present a case history of a patient with SVC with a catheter used for chemotherapy, which was successfully treated with catheter-directed (intraclot) infusion thrombolytic therapy with urokinase.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4199ea8a0a6847fa5a04d0368aa8420e https://pubmed.ncbi.nlm.nih.gov/17403633 Zobrazit plný text záznamu Full text from SpringerLink